Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Preclinical results presented for IKur inhibitor BMS-919373

Aug. 24, 2015

Novel aldosterone synthase inhibitors active in monkeys

Aug. 24, 2015

Factor XIa and KLKB1 inhibitors reported in BMS patent

Aug. 21, 2015

Edge Therapeutics reports topline phase I/II NEWTON trial data

Aug. 20, 2015

Theravance Biopharma patent discloses NEP inhibitors

Aug. 19, 2015

Bristol-Myers Squibb patents factor XIa and KLKB1 inhibitors

Aug. 19, 2015

First inhalable prostacyclin IP receptor agonist for pulmonary arterial hypertension

Aug. 18, 2015

Bristol-Myers Squibb patents factor XIa and KLKB1 inhibitors

Aug. 17, 2015

Azapeptide analogue exerts cardioprotective effects

Aug. 17, 2015

Topline results from phase I study of vonapanitase in symptomatic peripheral artery disease

Aug. 14, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...